stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy

Please see updated information from the FDA

You'll see stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy.

This is due to new evidence of a higher risk of miscarriage and birth defects in women taking mycophenolate to prevent transplant rejection.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote